M P Raitanen
Overview
Explore the profile of M P Raitanen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
79
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Raitanen M, Leppilahti M, Tuhkanen K, Forssel T, Nylund P, Tammela T
Ann Chir Gynaecol
. 2002 Feb;
90(4):261-5.
PMID: 11820414
Background And Aims: Cystoscopy and urine cytology are the standard tools for monitoring superficial bladder cancer. The sensitivity of cystoscopy is, however, limited to the tumours that can be visualised,...
2.
Raitanen M, Aine R, Kylmala T, Kallio J, Liukkonen T, Tammela T
Ann Chir Gynaecol
. 2002 Feb;
90(4):256-9.
PMID: 11820413
Background And Aims: Urine cytology is gold standard for clinical tests used in the diagnosis and follow-up of bladder cancer. Cytology, however, exhibits variable sensitivity depending on tumour grade and...
3.
Raitanen M, Hellstrom P, Marttila T, Korhonen H, Talja M, Ervasti J, et al.
Eur Urol
. 2001 Nov;
40(4):422-6.
PMID: 11713397
Objectives: The BTA stat is a rapid, non-invasive, qualitative urine test that detects bladder tumor-associated antigen (human complement factor H related protein) in urine. The sensitivity of this test is...
4.
Raitanen M, Kaasinen E, Rintala E, Hansson E, Nieminen P, Aine R, et al.
Br J Cancer
. 2001 Aug;
85(4):552-6.
PMID: 11506495
The purpose of the study was to determine, in addition to well-known prognostic factors, histological grade, stage, tumour size and multiplicity, the correlation of BTA stat Test on disease free...
5.
Raitanen M, Kaasinen E, Lukkarinen O, Kauppinen R, Viitanen J, Liukkonen T, et al.
Urology
. 2001 Apr;
57(4):680-4.
PMID: 11306380
Objectives: To evaluate the role of a positive BTA stat Test result in patients with negative cystoscopic findings. Methods: Five hundred one consecutive patients in follow-up for bladder cancer were...
6.
Raitanen M, Marttila T, Nurmi M, Ala-Opas M, Nieminen P, Aine R, et al.
J Urol
. 2001 Feb;
165(2):374-7.
PMID: 11176376
Purpose: The BTA stat test is a rapid, noninvasive, qualitative urine test that detects bladder tumor associated antigen (human complement factor H related protein) in urine. We compared BTA stat...
7.
Raitanen M, Marttila T, Kaasinen E, Rintala E, Aine R, Tammela T
J Urol
. 2000 May;
163(6):1689-92.
PMID: 10799161
Purpose: We compared the sensitivity of the BTA statdagger test, a rapid, noninvasive, qualitative urine test that detects bladder tumor associated antigen (human complement factor H related protein) in urine,...
8.
Raitanen M, Tammela T
Scand J Urol Nephrol
. 1999 Oct;
33(4):234-6.
PMID: 10515085
Objective: The Bard BTA stat Test is a new, rapid, non-invasive qualitative test that detects bladder tumour-associated antigen (human Complement Factor H-related protein) in urine. The objective of this study...
9.
Raitanen M, Tammela T, Kallioinen M, Isola J
J Urol
. 1997 Apr;
157(4):1250-3.
PMID: 9120913
Purpose: The alterations in deoxyribonucleic acid (DNA) ploidy and p53 expression during progression of bladder cancer were determined. Materials And Methods: p53 Expression and DNA ploidy were studied in 51...
10.
Raitanen M, Lukkarinen O
Br J Urol
. 1995 Dec;
76(6):697-701.
PMID: 8535711
Objectives: To evaluate the efficacy of intravesical epirubicin with or without alpha 2b-interferon (alpha 2b-IFN) as a prophylactic treatment for recurrent superficial transitional cell carcinoma (TCC) of the urinary bladder....